PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Microbiology and System Biology, Netherlands Organisation for Applied Scientific Research, The Hague, The Netherlands.\', \'Vascular Medicine, Amsterdam UMC, Academic Medical Center Amsterdam, Amsterdam, The Netherlands.\', \'Clinical Epidemiology, Biostatistics and Bioinformatics, Amsterdam UMC, Academic Medical Center Amsterdam, Amsterdam, The Netherlands.\', \'Faculty of Health Medicine and Life Sciences, University of Maastricht, Maastricht, The Netherlands.\', \'Cardiology, Amsterdam UMC, Academic Medical Center Amsterdam, Amsterdam, The Netherlands.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1093/ehjcvp/pvaa053
?:hasPublicationType
?:journal
  • European heart journal. Cardiovascular pharmacotherapy
is ?:pmid of
?:pmid
?:pmid
  • 32464637
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • The mechanistic overview of SARS-CoV-2 using angiotensin-converting enzyme 2 to enter the cell for replication: possible treatment options related to the renin-angiotensin system.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all